microRNAs target SRSF7 splicing factor to modulate the expression of osteopontin splice variants in renal cancer...

Area of Science:

• Molecular Biology
• Cancer Genetics
• RNA Biology

Background:

• SRSF7 (Serine/Arginine-rich Splicing Factor 7) is a key splicing factor regulating cancer-related genes.
• The regulatory mechanisms governing SRSF7 expression remain largely uncharacterized.

Purpose of the Study:

• To elucidate the regulatory mechanisms controlling SRSF7 expression in cancer cells.
• To investigate the functional impact of SRSF7 regulation on cancer cell behavior.

Main Methods:

• Analysis of microRNA (miRNA) regulation of SRSF7.
• Identification of specific miRNAs (miR-30a-5p and miR-181a-5p) targeting SRSF7.
• Experimental validation of a feedback loop between SRSF7 and target miRNAs.
• Assessment of SRSF7 silencing effects on osteopontin splicing and renal cancer cell proliferation.

Main Results:

• SRSF7 expression is directly regulated by specific microRNAs (miRNAs).
• A novel feedback loop exists where SRSF7 and miRNAs mutually regulate each other's expression.
• Silencing SRSF7 alters osteopontin splice variant expression and reduces renal cancer cell proliferation.

Conclusions:

• MicroRNAs, specifically miR-30a-5p and miR-181a-5p, play a critical role in regulating SRSF7 expression in cancer.
• The identified feedback loop represents a new regulatory mechanism in cancer biology.
• Targeting the SRSF7-miRNA axis may offer therapeutic strategies for renal cancer by affecting cell proliferation and alternative splicing.